About UltraShape
UltraShape is a Healthcare company based in Irvine (United States) founded in 2002, and was acquired by Candela Medical in February 2012. Non-invasive fat cell destruction for body contouring. UltraShape has raised $15 million across 1 funding round from investors including Candela Medical, Polaris Partners and Minitoto. Its chief executive, as recorded, is Assaf Eyal. Its focus areas include Life Sciences, Obesity, Medical Devices and Therapeutic Devices. Its competitors include Zeltiq, Standard Bariatrics and CoolSculpting; 2 of its 3 listed competitors have raised funding.
Company details
Ultrashape was founded in 2002 in Irvine, United States, focusing on medical technology for non-invasive fat reduction. Ultrasound-based systems are developed, manufactured, and marketed to target and destroy fat cells, enabling body contouring and sculpting procedures. The company went public in 2010 and was acquired by Syneron Medical in 2012, with operations centered in the aesthetics sector.
- Headquarters Irvine, United States
- Stage Acquired
- SectorsHealthcare
- Website ultrashape.com
- Social LinkedIn X Facebook
- Acquired by Candela Medical (Feb 2012)
- Total Equity Funding$15M (USD)
in 1 rounds
- Latest Funding Round$15M (USD), Series A
Mar 2006
- InvestorsCandela Medical
& 2 more
- Acquired byCandela Medical
(Feb 2012)
Funding Insights of UltraShape
UltraShape has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series A round of $15 million completed in March 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15M
- Total Rounds 1
- Last Round Series A — $15M
- First Round $15M
(Mar 2006)
- Investors Count 2
All 1 funding rounds of UltraShape with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2006 | $15M | Series A | – | Polaris Partners |
3 investors in total: 3 institutional.
Investors in UltraShape
UltraShape has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Candela Medical, Polaris Partners and Minitoto.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
US focused venture capital firm | polarispartners.com | Boston, United States | ||
Minitoto is recognized as a leading online toto slot provider. | israelseed.com | Indonesia | ||
Multiple medical devices for dermatological health are developed. | 1970 | candelamedical.com | Amsterdam, Netherlands |
Investor details for UltraShape
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of UltraShape
1 people are tracked at UltraShape (1 in leadership).
| Name | Role | Group |
|---|---|---|
Assaf Eyal | CEO & President | Leadership |
Complete people profiles for UltraShape
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of UltraShape
4 dated milestones of UltraShape across 10 years, from founding to its latest funding, stage changes and deals.
- Founded UltraShape is founded.
- Funding First funding round of $15.0M.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Candela Medical.
Competitors of UltraShape
UltraShape has 3 listed competitors in our database, 2 of them funded. They include Zeltiq, Standard Bariatrics and CoolSculpting.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zeltiq.com | 2005 | Pleasanton, United States | $70.42M | Controlled cooling technology is developed for non-surgical fat reduction. | ||
| standardbariatrics.com | 2014 | Cincinnati, United States | $35.5M | 34 | Medical devices for obesity surgical treatment are provided. | |
| coolsculpting.com | 2005 | Pleasanton, United States | 82 | Non-surgical fat reduction is achieved through controlled-cooling technology. |
Detailed competitors of UltraShape
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of UltraShape
Websites that share an audience with UltraShape (ultrashape.com).
Websites whose visitors overlap most with UltraShape. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| givenimaging.com | 100% | View details | |||
superdimension.com | superdimension.com | 100% | – | ||
| medigus.com | 100% | #7,725,859 | View details | ||
medical.philips.com | medical.philips.com | 100% | – | ||
fusfoundation.org | fusfoundation.org | 91% | #593,619 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for UltraShape
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Metabolic Diseases
3 companies that operate in the same segment as UltraShape (Metabolic Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Satiety induction through digestable gastric balloon introduced via a swallowed capsule | 2009 | Wellesley, Massachusetts, United States | USD 174.04 M | USD 32.11 M | 137 | |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies | 2010 | Boston, Massachusetts, United States | USD 84 M | USD 189.76 M | 283 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about UltraShape
UltraShape was founded in 2002 and raised its 1st funding round 4 years after it was founded.
UltraShape is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Assaf Eyal is the CEO of UltraShape, as recorded in our data.
UltraShape is a funded company, having raised a total of $15M across 1 funding round to date. The company's 1st funding round was a Series A of $15M, raised on Mar 2006.
Ultrashape was founded in 2002 in Irvine, United States, focusing on medical technology for non-invasive fat reduction. Ultrasound-based systems are developed, manufactured, and marketed to target and destroy fat cells, enabling body contouring and sculpting procedures. The company went public in 2010 and was acquired by Syneron Medical in 2012, with operations centered in the aesthetics sector.
UltraShape's top competitors include CoolSculpting, Standard Bariatrics and Zeltiq.
UltraShape has 3 investors. Key investors include Candela Medical, Polaris Partners, and Minitoto.
Yes. UltraShape was acquired by Candela Medical in February 2012.